Compare NOG & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NOG | PRGO |
|---|---|---|
| Founded | 2006 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.8B |
| IPO Year | N/A | 1991 |
| Metric | NOG | PRGO |
|---|---|---|
| Price | $24.86 | $13.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $29.57 | $22.50 |
| AVG Volume (30 Days) | 2.1M | ★ 4.1M |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | 7.24% | ★ 8.63% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.82 | N/A |
| Revenue | $2,050,402,000.00 | ★ $4,281,800,000.00 |
| Revenue This Year | $20.20 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.66 | ★ N/A |
| Revenue Growth | ★ 2.50 | N/A |
| 52 Week Low | $19.88 | $12.17 |
| 52 Week High | $42.35 | $30.93 |
| Indicator | NOG | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 68.06 | 32.48 |
| Support Level | $20.87 | $13.34 |
| Resistance Level | $23.08 | $14.12 |
| Average True Range (ATR) | 0.83 | 0.47 |
| MACD | 0.39 | 0.34 |
| Stochastic Oscillator | 85.42 | 66.41 |
Northern Oil & Gas Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil and natural gas properties. Its principal business is crude oil and natural gas exploration, development, and production. The company's oil and natural gas sales come from three geographic areas in the United States: the Williston Basin (North Dakota and Montana), the Permian Basin (New Mexico and Texas), the Uinta Basin, and the Appalachian Basin (Pennsylvania and Ohio).
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.